Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Race Oncology Ltd. ( (AU:RAC) ) is now available.
Race Oncology Ltd announced a change in the director’s interest, specifically regarding Dr. Sergio Scrofani’s securities. On November 25, 2025, Dr. Scrofani acquired 23,983 options exercisable at $4.69, expiring on November 24, 2029, following shareholder approval. This change reflects the company’s ongoing governance and shareholder engagement, potentially impacting its strategic direction and stakeholder confidence.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies. Its primary product offerings are centered around innovative cancer treatment solutions, aiming to address unmet medical needs in oncology.
Average Trading Volume: 546,429
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$514.5M
For an in-depth examination of RAC stock, go to TipRanks’ Overview page.